-The Indian Express The aftermath of the terrible deaths of women who underwent sterilisation surgeries in Bilaspur in Chhattisgarh has been full of stories about what actually happened. Spurious drugs and an overenthusiastic doctor who cut corners on ensuring quality vie for immediate blame. Beyond these, many have spoken about pervasive biases of gender and caste that wreak havoc on the lives of poor women, and also of family planning policies...

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...

-The News Minute The use of plastic or polyethylene terephthalate (PET) bottles for packaging medicines such as syrups and liquid orals has been banned by the government. Reports say that this ban will lead a price hike for certain drugs meant for children, women and senior citizens. According to a Times of India report SV Veeramani, president, Indian Drug Manufacturers Association (IDMA) confirmed the move, "There would be estimated 25-30% cost increase...

-Economic and Political Weekly The National Democratic Alliance government has constituted the IPR Think Tank which, among other things, is to draft the National Intellectual Property Rights Policy. India may not have a policy per se but it has a strong legislation on IPRs, a functioning patents office and mechanisms to grant patents as well as protect consumer interests. The Think Tank has other issues it needs to address, but is...

-Deccan Chronicle Prime Minister Narendra Modi may be patting himself on the back because President Barack Obama has agreed to India's position on food stockholding norms in World Trade Organisation (WTO). However, New Delhi seems to be bending over backwards to accommodate the American government and giant multinational corporations (MNCs) in the pharmaceutical industry, which will work to the detriment of our country's interests. In less than six months, the Modi government...